1. Electroencephalographic signatures of pain and analgesia in rats.
- Author
-
LeBlanc BW, Bowary PM, Chao YC, Lii TR, and Saab CY
- Subjects
- Animals, Cerebral Cortex drug effects, Disease Models, Animal, Electroencephalography, Freund's Adjuvant toxicity, Functional Laterality, Hyperalgesia drug therapy, Hyperalgesia etiology, Male, Neuralgia chemically induced, Pain Measurement, Rats, Rats, Sprague-Dawley, Wakefulness, Anesthetics, Inhalation therapeutic use, Brain Waves drug effects, Cerebral Cortex physiopathology, Isoflurane therapeutic use, Neuralgia drug therapy, Neuralgia physiopathology
- Abstract
Pain modulates rhythmic neuronal activity recorded by Electroencephalography (EEG) in humans. Our laboratory previously showed that rat models of acute and neuropathic pain manifest increased power in primary somatosensory cortex (S1) recorded by electrocorticography (ECoG). In this study, we hypothesized that pain increases EEG power and corticocortical coherence in different rat models of pain, whereas treatments with clinically effective analgesics reverse these changes. Our results show increased cortical power over S1 and prefrontal cortex (PFC) in awake, freely behaving rat models of acute, inflammatory and neuropathic pain. Coherence between PFC and S1 is increased at a late, but not early, time point during the development of neuropathic pain. Electroencephalography power is not affected by ibuprofen in the acute pain model. However, pregabalin and mexiletine reverse the changes in power and S1-PFC coherence in the inflammatory and neuropathic pain models. These data suggest that quantitative EEG might be a valuable predictor of pain and analgesia in rodents.
- Published
- 2016
- Full Text
- View/download PDF